Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability.
about
The Current Landscape of Genetic Testing in Cardiovascular Malformations: Opportunities and ChallengesReturn of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).A new case of de novo 19p13.2p13.12 deletion in a girl with overgrowth and severe developmental delayComparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromesThe clinical impact of chromosomal microarray on paediatric care in Hong Kong.Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncology.Epilepsy and the new cytogenetics.Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis.Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarrayGenetic testing and genetic counseling among Medicaid-enrolled children with autism spectrum disorder in 2001 and 2007.Application of array comparative genomic hybridization in 256 patients with developmental delay or intellectual disability.Issues surrounding the health economic evaluation of genomic technologies.Chromosomal microarray testing influences medical management.Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.From genetics to genomics of epilepsy.Prenatal diagnosis of fetal aneuploidies: post-genomic developments.How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.Cost savings through molecular diagnosis for hereditary hemorrhagic telangiectasia.Genetic testing practices in infants with congenital heart disease.The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study.Chromosomal microarray impacts clinical management.Microarray as a first genetic test in global developmental delay: a cost-effectiveness analysis.Clinical and Molecular Cytogenetic Characterisation of Children with Developmental Delay and Dysmorphic Features.Derivative chromosomes involving 5p large rearranged segments went unnoticed with the use of conventional cytogenetics.An economic analysis of prenatal cytogenetic technologies for sonographically detected fetal anomalies.Development and pilot testing of a tool to calculate parental and societal costs of raising a child with intellectual disability
P2860
Q26738380-89CD25E4-735F-43DD-855A-845DC46EFF8CQ30557139-063AD991-97A6-4D85-87AC-AD35D3CFBAEBQ33799838-047C1AC5-4EB2-414B-A477-D73C469D59DBQ34243496-27E8C9B5-7247-4E71-B680-D76320DA1835Q34343633-3F95737E-2C8D-4571-B6B8-CB04E5B47B70Q34452116-8B802EB4-4E9E-4A6E-9E04-3D7269AACDB8Q34814385-7DE88285-B663-43F7-BB5B-130242EDCEB1Q35287159-249069BA-6301-4B68-BC7D-71E85047A58BQ35751507-33268C24-F771-483A-98A3-1053CC890C40Q35959752-0459E64B-5C99-4C27-8F84-ED03DE5D4C83Q36614115-5A71D07C-6CDE-4190-BAD5-03479D331E2EQ37540387-02B832BA-AB41-466A-B86F-D0B52B118F43Q37541151-13215AEE-E43F-4E34-9B48-F7D6BD9DB6C9Q37895879-865BFB15-961C-4073-ACCF-02FC0F1E26A3Q37953135-8F53EF19-D7B8-4CEE-8B5F-2CB1EBB4950CQ38687777-889A4594-77EC-4B02-8CA4-2AFAFD46169FQ39611303-49D4C822-5EFC-4F3F-82C1-4E111D8907B9Q39850180-1958CF93-E3C4-485D-B789-FDC13CBCB55DQ43494882-53BD9FAF-9EE3-44EC-A941-66C26B9CFE83Q45130977-DE949C91-83BC-4652-8F5A-682D57791BC7Q46505593-1F30BE71-A9FF-411E-9ECA-E09E8CD2F8B5Q50195466-D5909600-0A8C-451B-A74B-D3D2741AB6CBQ50763347-5214A582-A5F6-4E33-B252-7DC929401BB5Q51857358-1B6727E6-B234-430A-8E7D-85270A51E6C1Q55128812-6640D932-F175-4721-BF8D-A203EBFE4249Q55445702-E79B4559-8911-4D8F-A124-5D16D05C1BD6Q55526165-5EDA92D3-98E9-4103-BDE6-04F043D64636Q57994490-3742EA07-B89C-4AA0-BAF4-71C84B0702FE
P2860
Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Value for money? Array genomic ...... es of intellectual disability.
@ast
Value for money? Array genomic ...... es of intellectual disability.
@en
type
label
Value for money? Array genomic ...... es of intellectual disability.
@ast
Value for money? Array genomic ...... es of intellectual disability.
@en
prefLabel
Value for money? Array genomic ...... es of intellectual disability.
@ast
Value for money? Array genomic ...... es of intellectual disability.
@en
P2860
P1476
Value for money? Array genomic ...... es of intellectual disability.
@en
P2093
Carlo A Marra
P2860
P304
P356
10.1016/J.AJHG.2010.03.009
P407
P577
2010-04-15T00:00:00Z